1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Fuse Medical, Inc.

Fuse Medical, Inc.

FZMD
Fuse Medical, Inc.US flagOther OTC
0.02
USD
- -
- -
1.48MMarket Cap
Fuse Medical, Inc.
FZMD
(Other OTC)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
0.36
- -
0.25
0.27
3.57
1.65
0.39
0.33
0.3
0.29
0.25
0.26
Revenue per Share
-0.35
-0.47
-0.67
-0.5
-0.42
0.15
- -
-0.37
-0.13
0.42
0.04
0.06
-0.05
-0.02
-0.02
0.04
0.05
Basic EPS, GAAP
-0.29
-0.43
-0.45
-0.55
-0.22
0.11
- -
-0.32
-0.06
0.39
0.1
0.04
- -
- -
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
7.33
- -
0.07
- -
0.01
- -
0.33
0.12
- -
- -
- -
- -
- -
- -
Dividend per Share
-11.59
-12.06
-12.72
-12.82
-13.21
0.1
- -
-0.38
-0.36
0.02
0.04
0.02
-0.03
-0.05
-0.07
-0.02
-0.02
Book Value per Share
9.16
8.69
8.16
0.24
-0.18
0.09
- -
0.05
- -
1.36
-0.55
-0.04
-0.06
-0.07
-0.1
-0.05
-0.05
Tangible Book Value per Share
- -
- -
- -
- -
- -
3
- -
4
6
7
16
68
70
70
70
74
70
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
- -
1
2
26
26
26
23
21
20
19
18
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
41.16
- -
-107.77
-47.24
12.32
3.23
-7.43
-14.92
-4.8
-10.75
-4.37
-1.3
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
-1
-1
3
1
4
-3
-1
-2
3
4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
5.51
- -
- -
- -
- -
0.76
0.72
Effective Tax Rate (%)
- -
- -
- -
- -
- -
41.1
- -
-149.3
-47.81
11.75
2.65
15.02
-14.48
-6.69
-7.78
16.62
19.72
Profit Margin (%)
2
2
2
- -
- -
- -
1
- -
- -
10
10
10
6
5
3
1
1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
2
2
2
- -
- -
- -
- -
- -
- -
11
-8
1
-1
-2
-3
- -
- -
Total Equity
- -
- -
- -
- -
- -
253.69
- -
- -
- -
50.77
- -
- -
- -
- -
- -
-270.32
-408.46
Return on Invested Capital (%)
- -
- -
- -
- -
- -
-30.98
- -
- -
- -
430.95
21.71
- -
- -
- -
- -
-425.41
-344.79
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
168.5
370.16
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
74
74
74
Market Capitalization
11
2
4

Working Capital

FRC

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
Total Current Assets
14
12
13
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
4
3
3
Inventories
9
9
9
Total Current Liabilities
12
11
12
Payables & Accruals
10
9
10
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21,323.04%
-51.47%
-90.94%
Free Cash Flow
- -
-449.8%
-101.96%
Net Income, GAAP
- -
-11.85%
-295.11%
Sales/Revenue/Turnover
- -
-6.63%
-8.67%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
4
6
4
6
20
2022
5
5
5
5
19
2023
4
5
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.01
- -
-0.01
- -
-0.02
2022
-0.01
- -
- -
- -
0.04
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
T&L Co., Ltd. (340570.KQ)
Techno Medica Co., Ltd. (6678.T)
BICO Group AB (publ) (BICO.ST)
Duearity AB (publ) (DEAR.ST)
Allied Healthcare Products, Inc. (AHPI)
OncoSil Medical Ltd (OSL.AX)
Business
Fuse Medical, Inc. (FZMD) manufactures, distributes and wholesales medical device implants focused on orthopedics and spine, offering orthopedic implants including internal and external fixation products for foot and ankle; upper and lower extremity plating systems; total joint reconstruction implants for knee, hip and shoulder; soft tissue fixation and suture anchors for sports medicine; spinal implants for cervical, thoracolumbar, trauma and interbody fusion; hammertoe implants; compression staples and headed/headless cannulated screws; as well as osteo-biologics and regenerative products such as human allografts, demineralized bone matrix, tendons, amniotic membrane, dermal matrix, wound care solutions, bone void fillers, platelet rich plasma and bone marrow aspirate concentrate. The company, founded in 1968 and headquartered in Farmers Branch, Texas, serves hospitals, ambulatory surgical centers, medical facilities and sub-distributors primarily in the United States. Fuse completed acquisitions of CPM Medical Consultants in 2019, enhancing its distribution network for joint reconstruction, sports medicine, trauma and biologics, and Maxim Surgical in 2018, expanding its spinal fusion device manufacturing capabilities; it continues to develop new products including the Fuse FPS Foot Plating System and sterile packaged systems for ambulatory settings.

Company News

APIChatGPT

  • defenseworld.net

    Golf Rounds.com (OTCMKTS:FZMD) & Becton, Dickinson and Company (NYSE:BDX) Financial Survey

  • globenewswire.com

    Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results

  • businesswire.com

    Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix

  • businesswire.com

    Fuse Medical, Inc. Announces Initial Launch of Orbitum™ Compression Staple System

  • businesswire.com

    Fuse Medical, Inc. Announces First Quarter 2021 Financial Results

  • businesswire.com

    Fuse Medical, Inc. Announces First Quarter 2021 Financial Results

  • businesswire.com

    Fuse Medical, Inc. Announces Fiscal Year 2020 Financial Results

  • businesswire.com

    Fuse Medical, Inc. Announces Exclusive Agreement With Orthovestments, LLC for Manufacturing & Commercialization of the Orbitum™ Staple System

  • businesswire.com

    Fuse Medical, Inc. Enters Into Marketing Agreement With CarePICS Telehealth

  • businesswire.com

    Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio

  • businesswire.com

    Fuse Medical, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19